Lanisidenib
Lanisidenib is the inhibitor for isocitrate dehydrogenase that exhibits antineoplastic activity[1].
Product Specifications
UNSPSC
12352211
Target
Isocitrate Dehydrogenase (IDH)
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cancer
Smiles
FC(F)(C1)CC1NC([C@H](C2=C(C=CC=C2)Cl)N(C3=CC(F)=CC=C3)C([C@H]4N(C5=CC(C#N)=CC=N5)S(=O)(CC4)=O)=O)=O
Molecular Formula
C28H23ClF3N5O4S
Molecular Weight
618.03
References & Citations
[1]WHO-Volume38 Number4 2024
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-168980/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
CAS Number
[2135537-20-9]
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15199243 1 Vial
Lentiviral mouse Igf2bp1 shRNA (UAS) - Lentiviral mouse Igf2bp1 shRNA (UAS) plasmid
Ask
View Details 
MBS1468757-01 0.02 mg (E-Coli)
Recombinant Mycobacterium leprae 3-dehydroquinate dehydratase (aroQ)
Ask
View Details MBS1468757-02 0.1 mg (E-Coli)
Recombinant Mycobacterium leprae 3-dehydroquinate dehydratase (aroQ)
Ask
View Details MBS1468757-03 0.02 mg (Yeast)
Recombinant Mycobacterium leprae 3-dehydroquinate dehydratase (aroQ)
Ask
View Details MBS1468757-04 0.1 mg (Yeast)
Recombinant Mycobacterium leprae 3-dehydroquinate dehydratase (aroQ)
Ask
View Details 
MBS1468757-05 0.02 mg (Baculovirus)
Recombinant Mycobacterium leprae 3-dehydroquinate dehydratase (aroQ)
Ask
View Details